457 results on '"Pedram Argani"'
Search Results
2. Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
3. Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis
4. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
5. Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors
6. Two-color quantitative multiplex methylation-specific PCR
7. Ossifying Fibromyxoid Tumor of the Genitourinary Tract
8. Nephrogenic rest vs immature teratoma associated with lumbosacral lipomyelomeningocele: a case report and review of the literature
9. MED15::TFE3 Renal Cell Carcinomas: Report of Two New Cases and Review of the Literature Confirming Nearly Universal Multilocular Cystic Morphology
10. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia
11. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma
12. Primary renal sarcoma with <scp>SS18</scp> :: <scp>POU5F1</scp> gene fusion
13. Data from Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression
14. Supplementary Figure 3 from Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78
15. Supplementary Table 1 from Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
16. Supplementary Data from Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
17. Supplementary Table 2 from Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
18. Data from Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
19. Supplementary Figure 4 from Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78
20. Supplementary Table 3 from Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
21. Data from Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78
22. Data from Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer
23. Data from Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
24. Supplementary Data from Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression
25. Supplementary Figure 5 from Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78
26. Supplementary Methods, Figures 1 - 3, Tables 1 - 4 from Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
27. Data from Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
28. Supplementary Figure 1 from Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78
29. Supplementary Figure 2 from Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78
30. Supplementary Data from Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer
31. Supplementary Table 3 from Genetic and Phenotypic Diversity in Breast Tumor Metastases
32. Data from Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer
33. Supplementary Figure Legends from The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk
34. Supplementary Figure 3 from Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
35. Supplementary Table 1 and Figures 1-4 from TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition
36. Supplementary Table 1, Figure 1 from Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
37. Supplementary Figure 2 from Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
38. Supplementary Methods and Figure Legends 1-4 from TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition
39. Data from Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
40. Supplementary Figures 1 - 8 from Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation
41. Supplementary Figure 1 from Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
42. Supplementary Table 4 from Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
43. Supplementary Table 5 from Genetic and Phenotypic Diversity in Breast Tumor Metastases
44. Supplementary Figure 2 from Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
45. Supplementary Methods from The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk
46. Supplementary Table 3 from Cancer-Related Epigenome Changes Associated with Reprogramming to Induced Pluripotent Stem Cells
47. Supplementary Figures 1-12, Methods, Table 1 from Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition
48. Supplementary Table 3 from Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
49. Supplementary Materials and Methods, Figures 1 -9, Tables 1 - 4 from Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer
50. Supplementary Methods from Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.